within NIH and throughout the scientific community. It not only articulated new priorities within women's health research, but also strongly reinforced existing areas such as interdisciplinary, gender-specific research.
Over the past two decades, advancement of gender medicine has required systematic dissipation of two myths. First, gender medicine is not akin to women's health, even though it was originally derived through advocacy of women's health initiatives. As is evident from the examples described below, advancing gender medicine improves outcomes for both men and women. Second, sex and gender medicine is not restricted to reproductive organs -socalled 'bikini medicine'. Every cell has a sex and influences the biological manifestation of disease. It is important to consider sex/gender in the clinical setting as well as in research in order to better understand the differences and the effect of these factors on patient outcomes. The newest NIH mandate in May 2014 requiring all basic science research to include both male and female cells further validates this concept. 4 
Applying the Gender Lens to Emergency Care -From Bench to Bedside
Emergency physicians (EPs) have observed consistent examples where sex and gender influences diagnosis, management, prognosis, and safety of their patients. For example, while taking care of patients with acute ST-elevation myocardial infarction, EPs are often surprised to see that some have negative angiograms despite meeting clinical criteria. This pattern seems to be more common in women as compared to men. We now understand that alternate forms of atherosclerosis that seem to be sex-specific 5 influence the care and prognosis of such patients. This biological difference likely also explains the higher prevalence of angina in women as compared to men. 6 And yet, current emergency department (ED) evaluation protocols are not sensitive enough to detect the alternate forms of atherosclerosis. Comparative effectiveness studies of current standard care compared with gender-specific algorithms are needed to optimize cost-effectiveness and clinical outcomes as has been done for coronary artery disease.
The benefits of advancing gender medicine in emergency care are not restricted to women only. Trauma resuscitation is one example where we see higher mortality in men compared to women across all age groups. 7 This is partly attributed to high-risk behaviors in men, but is also related to the hormonal milieu that exists at the time of insult. The immune response to the traumatic insult seems to be shaped by genetic polymorphism related to expression of the reproductive hormones. Estrogen boosts the immune response while testosterone suppresses it as is evident from the higher rates of post-traumatic pneumonia and multisystem organ failure in men as compared to women. 8 An excellent translation of the biological role of hormones on patient outcomes was seen in the ProTECT (Progesterone For the Treatment of Traumatic Brain Injury) trial that was spearheaded by emergency physicians. 9 The trial bridged the gap between basic science and clinical science by investigating the neuro-protective role of progesterone after traumatic brain injury.
Similar to disease processes, sex-and gender-specific differences have also been documented in areas of public health that form the core of emergency care. For instance, sex and gender differences have been documented in alcohol toxicity for similar levels of consumption due to differential rates of alcohol dehydrogenase activity in men versus women. 10 Gender also affects treatment for substance use disorders: women have more barriers to access, have more severe problems at treatment entry, and have lower rates of completion of substance use treatments. 11, 12 Specifically, the rate of opioids abuse has increased, and while men are more likely to have drug dependence, the escalation of drug use (especially prescription abuse) has been more dramatic over time in women. 13, 14 Women are also more likely to use opioids consistent with their prescription instructions, are more likely to use via the intended route of administration, and are more likely than men to use opioids to cope with psychiatric symptoms and negative affect. 15 Future efforts targeting opioid abuse will need to take these gender factors into account to ensure success. Similarly, with the closure of mental health institutions, the burden of acute psychiatric care has increased in emergency care. The rates of suicides have remained persistently higher in men compared to women. 16 Yet depressed women are not being hospitalized at the same rate as men after ED visits, identifying potential disparities in the delivery of crisis care for a potentially life-threatening disorder. 17 Further research with concomitant exploration of the causes and consequences of this practice pattern is necessary to move toward comparable treatment for individuals regardless of gender.
Emergency departments also provide a good forum to study the safety and efficacy of drugs. For example, the U.S. Food and Drug Administration recently reduced the dose of zolpidem in women, but not men, when new data highlighted an increased risk of driving-related accidents in women compared to men. 18 And last but not the least, a sharp increase has been noted in the use of advanced medical imaging in the ED; for example, ED computed tomography (CT) use increased by 330% from 1996 through 2007, with an estimated 13.9% increase in 2007 alone. 19 While the rates of CT use increased at similar rates for both male and female ED patients, women are more susceptible to the dangers of ionizing radiation from CT scanning. It is estimated that as many as 29,000 future malignancies may result from CT scans performed in the United States in 2007 alone, with malignancies in females accounting for a disproportionate amount (18,000 out of 29,000, or 62% of estimated future cancers). 20, 21 Furthermore, while men and women seem to receive CT scanning in equal numbers in the ED, ultrasound is often a more appropriate (and safer) initial diagnostic approach, particularly in the case of female pelvic pain. 22 The Affordable Care Act prioritized quality measures that address safety, effectiveness, patient-centeredness, appropriateness, and timeliness of care. To achieve these goals, sex-specific appropriateness criteria are needed for diagnostic imaging in the ED for common complaints.
The ED is the primary access point for health care for much of the U.S. population, with more than 136 million patient visits annually, and health care reform may not reduce ED volume. 23 EPs are clinicians who have the opportunity to apply gender medicine and observe significant trends in clinical care, generating important research questions and clinical trials. Gender medicine provides the biological and social framework to provide high-quality, safe, equitable, and cost-effective gender-specific care in the ED. With a 24-hour hospital presence and access to high-acuity patients, EPs are ideally positioned to lead gender-specific clinical studies for acute conditions and also to serve as vital partners in interdisciplinary research projects. Some collaborative networks (e.g. the Neurological Emergencies Treatment Trial Network) already exist; however, the science of gender medicine remains largely unexplored in emergency care. 24, 25 The ED also provides the primary access point for less life-threatening conditions such as substance abuse, mental health, and pain management (both acute and chronic). [26] [27] [28] Since a fifth of the US population is without health insurance and many more lack regular providers or rapid access to their providers, 29 the ED is often the only point of contact for studying this population. 30, 31 These and other examples provide a clear basis of why gender-specific research needs to be an integral part of emergency care.
Status of Gender Medicine in Emergency Care Research: Identifying a Gap
Despite a clear need, a 2011 review showed that EM is out of pace with other specialties such as cardiology, psychiatry, and oncology in applying the gender lens to its research. The review showed that only 2% of all EM studies reported gender-specific outcomes, and only 10% incorporated gender in their analyses (Figure 1) . 25 Twenty-one percent of EM studies did not report the gender of the participants. This manuscript alerted EPs to the absence of reporting of gender-specific outcomes for acute conditions. 25
AEM Consensus Conference -Filling a Critical Gap
The 2014 AEM conference on sex-and gender-specific research is culmination of a 3-year concerted effort by a dedicated team that wants to change these statistics. The organization, planning, and measures that led to its success are described elsewhere in this issue. 32 The conference and its agenda on May 13, 2014 proved timely with the announcement by the NIH on May 14, 2014 mandating basic science research to include both male and female cells. This issue of AEM is devoted to the consensus recommendations put forth by leaders in emergency care research aiming to promote research in sex and gender medicine.
Conclusions
The 2014 AEM consensus conference on sex-and gender-specific research was a multistakeholder symposium that was put together to fill a critical gap in emergency care research. On behalf of the conference organizing committee and the journal's editorial board, we thank the conference participants, patients, speakers, federal partners, and our generous supporters for making this day possible. We hope that the reader finds this AEM issue with the conference proceedings and original research stimulating and informative, and that these articles will catalyze research in these important areas.
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